AlphAIAlphAI — Financial news for AI agents
investing.comOCT 302 min read$CL

Colgate-Palmolive earnings beat by $0.04, revenue topped estimates

Colgate-Palmolive reported Q3 EPS of $0.97, beating estimates by $0.04, with revenue of $5.37B, exceeding expectations. The stock is up 2.04% in 3 months and 20.91% in 12 months. According to InvestingPro, the company's financial health is rated as 'good performance'.

Original reporting
investing.com
Published Oct 30, 2026, 11:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CL
Bullish
high confidence
Mentioned
$CL
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CLBullishMed
01

Why it matters

The earnings beat provides fresh positive data that may drive short‑term buying pressure, though the magnitude is modest.

02

Market read

The earnings surprise could generate a modest upside for CL and modestly boost consumer staples sentiment.

03

What to watch

Guidance outlook and margin trends were not discussed, which could temper the reaction.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Colgate-Palmolive released its third‑quarter earnings, showing a small beat on both EPS and revenue.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

Colgate-Palmolive reported Q3 EPS of $0.97, beating estimates by $0.04 and revenue of $5.37B, topping consensus of $5.34B.

Expected impact

potential modest upside as the market prices in the earnings beat

Evidence & confidence

The beat on both earnings and revenue provides fresh positive data, likely prompting short‑term buying pressure.

Market effects

Sector

Consumer staples may see a slight uplift as a major player posts a beat.

Regional

U.S. market sentiment could improve marginally in the consumer staples segment.

Global

Limited to U.S. equities; no broader global impact.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face a pull‑back.

Key entities

  • Company
    Colgate-Palmolive

    Consumer staples manufacturer reporting Q3 earnings.

Read at source← All news

StoryColgate-Palmolive posts Q3 2026 beat and raises full‑year Base Business EPS outlook

Also covered by

4 outlets

Related articles

NOV 2
$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

investing.com2 min
NOV 2
$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

investing.com2 min
NOV 2
$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

investing.com1 min
NOV 1
$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

finance.yahoo.com2 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

finance.yahoo.com3 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.

finance.yahoo.com3 min